Search
Now showing items 1-10 of 64
-
A review of national guidelines for management of COPD in Europe.
(European Respiratory Society, 2016-02)The quality of care can be improved by the development and implementation of evidence-based treatment guidelines. Different national guidelines for chronic obstructive pulmonary disease (COPD) exist in Europe and relevant ... -
Diagnosis, assessment, and phenotyping of COPD: beyond FEV1
(Dove Press, 2016-02-18)COPD is now widely recognized as a complex heterogeneous syndrome, having both pulmonary and extrapulmonary features. In clinical practice, the diagnosis of COPD is based on the presence of chronic airflow limitation, as ... -
Case finding for chronic obstructive pulmonary disease in people attending long-term condition clinics in primary care.
(Sage, 2016-04-12)Despite increased interest and awareness of chronic obstructive pulmonary disease (COPD), nearly half of the people with COPD remain undiagnosed. Inviting people at risk for screening is unlikely to be effective as many ... -
Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
(Elsevier, 2017-07)Chronic obstructive pulmonary disease (COPD) and asthma are leading causes of morbidity and mortality. This narrative review provides an appraisal of the pharmacological and clinical characteristics of tiotropium in COPD ... -
A hormonal effusion?
(BMJ, 2013-07) -
Treatment demands and differential treatment of patients with cystic fibrosis and their siblings: patient, parent and sibling accounts.
(Wiley, 2001-07)Cystic fibrosis (CF) is a progressive disease with no known cure. Advances in diagnosis and treatment have resulted in patients living longer and thus families live with the illness for longer. Treatments are becoming ... -
Fungal septicaemia in patients with cystic fibrosis associated with totally implantable venous access device system.
(Elsevier, 2007-09)Fungal septicaemia is a serious and potentially fatal condition. We report 4 cases in patients with Cystic Fibrosis (CF) associated with totally implantable venous access device system (TIVADS). -
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.
(BioMed Central, 2016-09-23)Management guidelines of chronic obstructive pulmonary disease (COPD) are mainly based on results of randomised controlled trials (RCTs), but some authors have suggested limited representativeness of patients included in ...